A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone
NCT03557450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2019-05-30
Summary
To evaluate if a commonly used medical bone scan, called positron emission tomography/computed tomography (PET/CT) with sodium fluoride can measure bone blood flow to the hip.
Conditions
- Normal Subjects
Interventions
- DEVICE
-
PET/CT Scan
PET/CT scanning with sodium fluoride
Sponsors & Collaborators
-
University of California, Davis
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-11
- Primary Completion
- 2019-03-25
- Completion
- 2019-03-25
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 ·Status: COMPLETED ·Phase: PHASE2
-
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
NCT01541358 ·Status: TERMINATED ·Phase: NA
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
NCT01224873 ·Status: UNKNOWN
-
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
NCT00282906 ·Status: COMPLETED ·Phase: NA
-
FDG-PET Imaging in Complicated Diabetic Foot
NCT00194298 ·Status: ACTIVE_NOT_RECRUITING
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
NCT00392938 ·Status: COMPLETED
-
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
NCT00956163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
NCT01501630 ·Status: COMPLETED
-
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
NCT06055764 ·Status: NOT_YET_RECRUITING
-
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.
NCT04080271 ·Status: COMPLETED
-
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
NCT00725387 ·Status: COMPLETED
-
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
NCT00414934 ·Status: UNKNOWN
-
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
NCT02167204 ·Status: COMPLETED ·Phase: NA
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
CUP Project PET/CT
NCT01469026 ·Status: UNKNOWN ·Phase: PHASE4
-
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
NCT02055586 ·Status: COMPLETED
-
Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)
NCT02876731 ·Status: COMPLETED ·Phase: NA
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
NCT05452005 ·Status: RECRUITING ·Phase: PHASE1
-
Feasibility Assessment of Next-generation PET Technology and Procedures
NCT03387618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
Correlation of PET-CT Studies With Serum Protein Analysis
NCT00547742 ·Status: COMPLETED
-
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
NCT05160480 ·Status: ENROLLING_BY_INVITATION